BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CREB1, ENSG00000118260, 1385 AND Treatment
16 results:

  • 1. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/creb1 axis.
    Ding Y; Huang Y; Zhang F; Gong L; Liang C; Ding K; He X; Ding X; Chen Y
    J Transl Med; 2023 Nov; 21(1):854. PubMed ID: 38008726
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. miR-450a exerts oncosuppressive effects in breast carcinoma by targeting creb1.
    Zhang Y; Han XX; Lin XM; Li Z; Zhang JH
    Kaohsiung J Med Sci; 2022 Jul; 38(7):643-652. PubMed ID: 35451558
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Examining the effect of obesity-associated gene variants on breast cancer survivors in a randomized weight loss intervention.
    Nguyen T; Irwin ML; Dewan AT; Cartmel B; Harrigan M; Ferrucci LM; Sanft T; Li F; Lu L; Salinas YD
    Breast Cancer Res Treat; 2021 Jun; 187(2):487-497. PubMed ID: 33677781
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Myxoid mesenchymal intraventricular brain tumour with EWSR1-creb1 gene fusion in an adult woman.
    Valente Aguiar P; Pinheiro J; Lima J; Vaz R; Linhares P
    Virchows Arch; 2021 May; 478(5):1019-1024. PubMed ID: 32632473
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Common cancer biomarkers of breast and ovarian types identified through artificial intelligence.
    Pawar S; Liew TO; Stanam A; Lahiri C
    Chem Biol Drug Des; 2020 Sep; 96(3):995-1004. PubMed ID: 32410355
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. breast Biopsy During Post-treatment Surveillance of Screen-Detected breast cancer Patients Yields High Rates of Benign Findings.
    Laws A; Xu Y; Kong S; Brisson AM; Bouchard-Fortier A; Quan ML
    Ann Surg Oncol; 2020 Aug; 27(8):2689-2697. PubMed ID: 32100221
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and creb1 expression.
    Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J
    Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials.
    Bilen MA; Patel A; Hess KR; Munoz J; Busaidy NL; Wheler JJ; Janku F; Falchook GS; Hong DS; Meric-Bernstam F; Habra MA; Naing A
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):167-71. PubMed ID: 27286994
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Racial and ethnic differences in adjuvant hormonal therapy use.
    Livaudais JC; Li C; John EM; Terry MB; Daly M; Buys SS; Habel L; Thompson B; Yanez ND; Coronado GD
    J Womens Health (Larchmt); 2012 Sep; 21(9):950-8. PubMed ID: 22731764
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs.
    Madak-Erdogan Z; Lupien M; Stossi F; Brown M; Katzenellenbogen BS
    Mol Cell Biol; 2011 Jan; 31(1):226-36. PubMed ID: 20956553
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fibroblast growth factor 2 regulates bone sialoprotein gene transcription in human breast cancer cells.
    Li Z; Wang Z; Yang L; Li X; Sasaki Y; Wang S; Araki S; Mezawa M; Takai H; Nakayama Y; Ogata Y
    J Oral Sci; 2010 Mar; 52(1):125-32. PubMed ID: 20339243
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression.
    Kijima I; Phung S; Hur G; Kwok SL; Chen S
    Cancer Res; 2006 Jun; 66(11):5960-7. PubMed ID: 16740737
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prevention and treatment of breast cancer by suppressing aromatase activity and expression.
    Chen S; Zhou D; Okubo T; Kao YC; Eng ET; Grube B; Kwon A; Yang C; Yu B
    Ann N Y Acad Sci; 2002 Jun; 963():229-38. PubMed ID: 12095949
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International breast cancer Study Group.
    Colleoni M; Price K; Castiglione-Gertsch M; Goldhirsch A; Coates A; Lindtner J; Collins J; Gelber RD; Thürlimann B; Rudenstam CM
    Eur J Cancer; 1998 Oct; 34(11):1693-700. PubMed ID: 9893654
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases.
    Reinfuss M; Stelmach A; Mitus J; Rys J; Duda K
    J Surg Oncol; 1995 Oct; 60(2):89-94. PubMed ID: 7564387
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Role of radiation therapy in the complex treatment of breast cancer].
    Pavlov AS; Datsenko VS
    Vopr Onkol; 1978; 24(8):48-54. PubMed ID: 695426
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.